Journal of Research and Development
Open Access

USA

Publications

• Extended Abstract   
  Nanomedicine 2017: Anti-fusion targeted nanomicellar theranostics: Novel antiviral strategies for respiratory syncytial virus infection-induced lung disease
  Author(s): Shyam S Mohapatra
  
  The respiratory syncytial virus (RSV), is an important pathogen that infects an estimated 64 million people and causes ~200,000 deaths globally every year. Despite progress in the biology of RSV, there is no effective treatment or vaccine against RSV infection. Currently, only high-risk infants receive antibody-based prophylaxis, which is expensive and moderately effective in reducing hospitalization. Therefore, a broadly applicable, effective and inexpensive approach to prevent or treat RSV-bronchiolitis or pneumonia remains an urgent unmet need. We have been investigating nanomedical approaches against RSV infection and have reported on .. View More»
  

  Abstract PDF